Clinical Trial Update: Treating Immuno-metabolic Depression With Anti-inflammatory Drugs [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating anti-inflammatory drugs for immuno-metabolic depression, with the trial currently listed as Acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Depressive Disorder, Major, Inflammation | Phase 3 | Status: ACTIVE_NOT_RECRUITING